These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1727952)

  • 1. Aspirin use and cardiovascular disease in women.
    D'Agostino RB; Cobb JL; Wolf PA; Wilson PW
    JAMA; 1992 Jan; 267(3):364-5. PubMed ID: 1727952
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
    Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for the prevention of cardiovascular disease.
    Lin KW
    Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acetylsalicylic acid in cardiovascular pathology: therapeutic news about an old acquaintance].
    Laporte JR
    Med Clin (Barc); 1988 Oct; 91(14):541-3. PubMed ID: 3063899
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for the prevention of cardiovascular disease: recommendation statement.
    Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The puzzle of aspirin and sex.
    Levin RI
    N Engl J Med; 2005 Mar; 352(13):1366-8. PubMed ID: 15755763
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on aspirin in the primary prevention of cardiovascular disease.
    Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
    Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lady aspirin for cardiovascular disease.
    Verheugt FW; Smith SC
    Lancet; 2005 Oct; 366(9492):1148-50. PubMed ID: 16198753
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
    N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
    Wynn RL
    Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
    [No Abstract]   [Full Text] [Related]  

  • 14. An aspirin a day. Still recommended for diabetes?
    Hieronymus L; Griffin S; Vora A
    Diabetes Self Manag; 2009; 26(6):23-6. PubMed ID: 20058718
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin prophylaxis for cardiovascular disease. U.S. Preventive Services Task Force.
    Am Fam Physician; 1989 Aug; 40(2):117-20. PubMed ID: 2667297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aspirin a day keeps the MI away (for some).
    Miser WF
    Am Fam Physician; 2002 May; 65(10):2000, 2003. PubMed ID: 12046769
    [No Abstract]   [Full Text] [Related]  

  • 17. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
    Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Hennekens CH; Dyken ML; Fuster V
    Circulation; 1997 Oct; 96(8):2751-3. PubMed ID: 9355934
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin in the primary prevention of cardiovascular disease.
    Hennekens CH; Buring JE
    Cardiol Clin; 1994 Aug; 12(3):443-50. PubMed ID: 7805078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin use in the prevention of cardiovascular events.
    Crutcher JM; Mallonee S; Daniels C
    J Okla State Med Assoc; 2007 Oct; 100(10):383-7. PubMed ID: 18085095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.